Titan Pharmaceuticals
TTNP
#10544
Rank
HK$48.01 M
Marketcap
HK$36.09
Share price
-3.76%
Change (1 day)
16.35%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -HK$21.86 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$36.85 Million, an increase over its 2023 earnings that were of -HK$43.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$21.86 Million-40.69%
2024 -HK$36.85 Million-15.5%
2023 -HK$43.61 Million-45.43%
2022 -HK$79.91 Million16.29%
2021 -HK$68.71 Million-907.36%
2020 HK$8.51 M-106.6%
2019 -HK$0.13 Billion82.4%
2018 -HK$70.65 Million-36.93%
2017 -HK$0.12 Billion-378.62%
2016 HK$40.2 M-145.53%
2015 -HK$88.31 Million369.37%
2014 -HK$18.82 Million-125.9%
2013 HK$72.64 M-177.74%
2012 -HK$93.44 Million13.59%
2011 -HK$82.26 Million74.37%
2010 -HK$47.18 Million3.61%
2009 -HK$45.53 Million
2007 -HK$0.15 Billion12.08%
2006 -HK$0.13 Billion-28.65%
2005 -HK$0.19 Billion-10.03%
2004 -HK$0.21 Billion-6.08%
2003 -HK$0.22 Billion-14.76%
2002 -HK$0.26 Billion32.52%
2001 -HK$0.19 Billion27.55%
2000 -HK$0.15 Billion62.5%
1999 -HK$91.23 Million4.04%
1998 -HK$87.69 Million49.33%
1997 -HK$58.72 Million-27.88%
1996 -HK$81.43 Million13.04%
1995 -HK$72.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.39 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.57 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$0.95 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$0.65 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$93.99 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$2.25 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA